NCT06931886Enrolling by invitation
Pulmonary Hypertension Inspiratory Training
Effects of Inspiratory Muscle Strength Training on Pulmonary Hypertension: A Six Week Study
Source: ClinicalTrials.gov · Last updated 17 Dec 2025
Brief summary (registry, in English)
This study is examining the effects of six weeks of inspiratory muscle strength training (IMST) on outcomes related to pulmonary hypertension. This study leverages previous cardiopulmonary exercise test (CPET) results and a pre-existing upcoming CPET to examine the effects of IMST on cardiopulmonary pressures and exercise tolerance and ability.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 4 (estimated)
- First submitted
- 9 Dec 2024
- Start date
- 25 Oct 2025
- Primary completion date
- May 2026
- Lead sponsor
- University of Arizona
- NCT number
- NCT06931886
What you commit to
- Study type: Interventional
- Planned participants: 4
- From 25 Oct 2025 to the primary completion date, May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of significant cardiovascular or respiratory conditions other than PH, including but not limited to:
- Chronic obstructive pulmonary disease
- Severe asthma
- Severe ischemic heart disease
- Left-sided heart failure
- History of a major cardiovascular event, such as a myocardial infarction or stroke, within the last 6 months
- Individuals with an implanted pacemaker or other significant cardiac devices
- History of neurological, respiratory, head and neck, or thoracic surgeries, or conditions such as a collapsed lung or perforated eardrum
- Individuals with any of the following: chronic laryngitis, chronic bronchitis, emphysema, pneumonia, tuberculosis, chronic cough, extremely high blood pressure (\>170/100), neurological problems, scoliosis, organ transplants, HIV or other immunocompromising conditions, or autoimmune disease.
Other
- Current smoker or have smoked in the last 10 years
- Unable or unwilling to undergo routine functional testing of their PH (i.e., 6-minute walk distance).
- Pregnant individuals or those actively trying to become pregnant
Who the study is looking for
- Diagnosed with PH defined by clinical guideline criteria
- Must already be scheduled for a clinical assessment of their PH within 8 weeks of enrolling in the study.
- Must have undergone an assessment of their PH in the last 18 months with no major changes in PH management or medication within that period.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Arizona Coordinator of this site? Confirm its status | Tucson | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.